The novel therapy of tirzepatide peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide343344.spintheblog.com/42406905/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment